YONKERS, NY -- (Marketwired) -- 12/04/14 -- (NASDAQ: CFRX) (NASDAQ: CFRXW) (NASDAQ: CFRXZ), a biotechnology company…
Continue ReadingTag: barer
ContraFect Submits Complete Response to IND Clinical Hold for CF-301
YONKERS, NY -- (Marketwired) -- 12/02/14 -- (NASDAQ: CFRX) (NASDAQ: CFRXW) (NASDAQ: CFRXZ), a biotechnology company…
Continue Reading
ContraFect Corporation Announces Third Quarter 2014 Results
YONKERS, NY -- (Marketwired) -- 11/14/14 -- (NASDAQ: CFRX) (NASDAQ: CFRXW) (NASDAQ: CFRXZ), a biotechnology company…
Continue Reading
ContraFect and National Institute for Viral Disease Control and Prevention, China CDC Sign Agreement to Collaborate on Universal Influenza Treatment
YONKERS, NY -- (Marketwired) -- 10/09/14 -- (NASDAQ: CFRX) (NASDAQ: CFRXW) (NASDAQ: CFRXZ), a biotechnology company…
Continue Reading
ContraFect Corporation to Present at the 13th Annual BIO Investor Forum
YONKERS, NY -- (Marketwired) -- 09/30/14 -- (NASDAQ: CFRX) (NASDAQ: CFRXW) (NASDAQ: CFRXZ), a biotechnology company…
Continue Reading
ContraFect Corporation Expands Senior Management Team
Hires Natalie Bogdanos as General Counsel
Continue Reading
ContraFect Corporation to Present at BioCentury–s 21st Annual NewsMakers in the Biotech Industry Conference
YONKERS, NEW YORK -- (Marketwired) -- 09/19/14 -- (NASDAQ: CFRX) (NASDAQ: CFRXW) (NASDAQ: CFRXZ), a biotechnology…
Continue Reading
ContraFect Corporation–s Universal Influenza Treatment Receives SBIR Funding
YONKERS, NY -- (Marketwired) -- 09/16/14 -- (NASDAQ: CFRX) (NASDAQ: CFRXW) (NASDAQ: CFRXZ), a biotechnology company…
Continue Reading